全文获取类型
收费全文 | 166835篇 |
免费 | 33303篇 |
国内免费 | 2494篇 |
专业分类
耳鼻咽喉 | 5335篇 |
儿科学 | 5662篇 |
妇产科学 | 2529篇 |
基础医学 | 5494篇 |
口腔科学 | 1851篇 |
临床医学 | 27714篇 |
内科学 | 51960篇 |
皮肤病学 | 7686篇 |
神经病学 | 15848篇 |
特种医学 | 6998篇 |
外科学 | 43879篇 |
综合类 | 292篇 |
现状与发展 | 72篇 |
一般理论 | 1篇 |
预防医学 | 7410篇 |
眼科学 | 3662篇 |
药学 | 2128篇 |
1篇 | |
中国医学 | 37篇 |
肿瘤学 | 14073篇 |
出版年
2024年 | 518篇 |
2023年 | 4886篇 |
2022年 | 1397篇 |
2021年 | 3523篇 |
2020年 | 6221篇 |
2019年 | 2456篇 |
2018年 | 7724篇 |
2017年 | 7609篇 |
2016年 | 8753篇 |
2015年 | 8758篇 |
2014年 | 15889篇 |
2013年 | 16120篇 |
2012年 | 6401篇 |
2011年 | 6495篇 |
2010年 | 10906篇 |
2009年 | 14712篇 |
2008年 | 6633篇 |
2007年 | 4921篇 |
2006年 | 7392篇 |
2005年 | 4607篇 |
2004年 | 3860篇 |
2003年 | 2831篇 |
2002年 | 2917篇 |
2001年 | 4301篇 |
2000年 | 3533篇 |
1999年 | 3651篇 |
1998年 | 3886篇 |
1997年 | 3635篇 |
1996年 | 3518篇 |
1995年 | 3365篇 |
1994年 | 2081篇 |
1993年 | 1680篇 |
1992年 | 1702篇 |
1991年 | 1682篇 |
1990年 | 1324篇 |
1989年 | 1441篇 |
1988年 | 1248篇 |
1987年 | 1035篇 |
1986年 | 1101篇 |
1985年 | 924篇 |
1984年 | 709篇 |
1983年 | 644篇 |
1982年 | 587篇 |
1981年 | 453篇 |
1980年 | 418篇 |
1979年 | 456篇 |
1978年 | 417篇 |
1977年 | 481篇 |
1975年 | 345篇 |
1972年 | 362篇 |
排序方式: 共有10000条查询结果,搜索用时 718 毫秒
81.
82.
83.
Status migrainosus is defined by the international classification of headache disorders (ICHD) criteria as a debilitating migraine lasting more then 72 hours. The epidemiology of status migrainosus is still unknown in adult and children, and frequently underdiagnosed. Children and adolescents often end up in the emergency room with an intractable headache that failed outpatient therapy. Six to seven percent of these children do not respond to acute infusion therapy and require hospitalization. It is imperative that more aggressive therapy is considered when patients are affected by a severe intractable headache to prevent further disability and returning the child to baseline activity. Multiple therapies are available for adults and children. Studies for acute therapy in the emergency room are available in adults and pediatric groups. Small studies are available for inpatient therapy in children and, along with available therapies for children and adolescents, are described in this review. A review of the literature shows growing evidence regarding the use of dihydroergotamine intravenously once patients are hospitalized. Effectiveness and safety have been proven in the last decades in adults and small studies in the pediatric populations. 相似文献
84.
85.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255
86.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310
87.
88.
89.
Munetaka Matoba Hiroyuki Tuji Yuzo Shimode Tamaki Kondo Kiyotaka Oota Hisao Tonami 《Journal of radiation research》2015,56(3):553-560
The aim of this study was to evaluate whether the lesion regression rate (ΔLR) based on the Response Evaluation Criteria in Solid Tumors (RECIST) criteria could be used for the prediction of treatment outcome in head and neck squamous cell carcinoma (HNSCC) patients treated with chemoradiotherapy (CRT) compared with FDG PET-CT. A total of 33 patients underwent MRI and PET-CT at pretreatment and at 8 weeks after CRT. We assessed the treatment outcome by analyzing the following parameters: the RECIST criteria, ΔLR, the European Organization for Research and Treatment of Cancer (EORTC) criteria, and pretreatment SUVmax of the primary tumor and node. The correlation between the analysis of the parameters and the results of the long-term follow-up of the patients was determined. The RECIST did not significantly correlate with locoregional control (LRC) or survival. The ΔLR was significantly lower for the lesions with locoregional failure (LRF) than for those with LRC. A threshold ΔLR of 48% revealed a sensitivity of 72.7% and specificity of 77.3% for the prediction of LRF. Progression-free survival (PFS) of patients with ΔLR ≥ 48% was significantly better than that of patients with ΔLR < 48% (P = 0.001), but not overall survival. There was a significant correlation between LRC and the EORTC (P = 0.02). The patients who achieved a complete response by the EORTC criteria showed significantly better PFS and overall survival (P = 0.01 and 0.04, respectively). The ΔLR was inferior to FDG PET-CT with respect to the prediction of patient survival; however, it may be useful for selecting patients in need of more aggressive monitoring after CRT. 相似文献
90.